Literature DB >> 12410501

Comparison of costs and safety of a suture-mediated closure device with conventional manual compression after coronary artery interventions.

Hans Rickli1, Martin Unterweger, Gabor Sütsch, Hans Peter Brunner-La Rocca, Markus Sagmeister, Peter Ammann, Franz W Amann.   

Abstract

The aim of this study was to assess costs and safety of immediate femoral sheath removal and closure with a suture-mediated closure device (Perclose, Menlo Park, CA) in patients undergoing elective (PCI). A total of 193 patients was prospectively randomized to immediate arterial sheath removal and access site closure with a suture-mediated closure device (SMC; n = 96) or sheath removal 4 hr after PCI followed by manual compression (MC; n = 97). In the SMC group, patients were ambulated 4 hr after elective PCI if hemostasis was achieved. In the MC group, patients were ambulated the day after the procedure. In addition to safety, total direct costs including physician and nursing time, infrastructure, and the device were assessed in both groups. Total direct costs were significantly (all P < 0.001) lower in the SMC group. Successful hemostasis without major complication was achieved in all patients. The time to achieve hemostasis was significantly shorter in the SMC group (7.1 +/- 3.4 vs. 22.9 +/- 14.0 min; P < 0.01) and 85% of SMC patients were ambulated on the day of intervention. Suture-mediated closure allows a reduction in hospitalization time, leading to significant cost savings due to decreased personnel and infrastructural demands. In addition, the use of SMC is safe and convenient to the patients. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12410501     DOI: 10.1002/ccd.10294

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  12 in total

Review 1.  Efficacy and safety of the perclose closer s device after neurointerventional procedures: prospective study and literature review.

Authors:  Kamran Khaghany; Firas Al-Ali; Thomas Spigelmoyer; Ron Pimentel; Kurt Wharton
Journal:  AJNR Am J Neuroradiol       Date:  2005 Jun-Jul       Impact factor: 3.825

2.  Postinterventional percutaneous closure of femoral artery access sites using the Clo-Sur PAD device: initial findings.

Authors:  Jörn Oliver Balzer; Wolfram Schwarz; Axel Thalhammer; Katrin Eichler; Thomas Schmitz-Rixen; Thomas J Vogl
Journal:  Eur Radiol       Date:  2006-05-10       Impact factor: 5.315

3.  Use of ultrasound in the insertion of a vascular closure device: a comparative retrospective study with the standard blind technique.

Authors:  Pierleone Lucatelli; Alessandro Cannavale; Carlo Cirelli; Alessandro d'Adamo; Filippo Maria Salvatori; Fabrizio Fanelli
Journal:  Radiol Med       Date:  2014-08-15       Impact factor: 3.469

4.  Initial experience with the AXERA 2 Femoral Access System in neurovascular procedures.

Authors:  Ramesh Grandhi; Nathan T Zwagerman; Xiaoran Zhang; Stephanie H Chen; Ashutosh P Jadhav; Tudor Jovin; Brian T Jankowitz
Journal:  Interv Neuroradiol       Date:  2015-05-26       Impact factor: 1.610

5.  Incidence of delayed angiographic femoral artery complications using the EXOSEAL vascular closure device.

Authors:  Ramesh Grandhi; Xiaoran Zhang; David Panczykowski; Phillip Choi; Christopher T Hunnicutt; Ashutosh P Jadhav; Andrew F Ducruet; Tudor Jovin; Brian Jankowitz
Journal:  Interv Neuroradiol       Date:  2015-05-26       Impact factor: 1.610

6.  Short-Term Safety and Efficacy of Femoral Vascular Closure after Percutaneous Coronary Intervention with Combination of the Boomerang(TM) Device and Intravenous Protamine Sulfate.

Authors:  Ching-Pei Chen; Huang-Kai Huang; Chien-Hsun Hsia; Yung-Ming Chang; Lee-Shin Lin; Cheng-Liang Lee
Journal:  Acta Cardiol Sin       Date:  2013-11       Impact factor: 2.672

7.  Quantitative impact of cardiovascular risk factors and vascular closure devices on the femoral artery after repeat cardiac catheterization.

Authors:  Klaus A Tiroch; Michael E Matheny; Frederic S Resnic
Journal:  Am Heart J       Date:  2010-01       Impact factor: 4.749

8.  Efficacy of femoral vascular closure devices in patients treated with anticoagulant, abciximab or thrombolytics during percutaneous endovascular procedures.

Authors:  Ha Young Kim; Sung Wook Choo; Hong Gee Roh; Heon Han; Sam Soo Kim; Ji Yeon Lee; Yul Ri Park; Sung Hoon Lee; Sung Wook Shin; Kwang Bo Park; Young Soo Do; Sung Ki Cho; In Ho Lee; Sung Mok Kim; Hong Sik Byun; Pyoung Jeon
Journal:  Korean J Radiol       Date:  2006 Jan-Mar       Impact factor: 3.500

Review 9.  Network Meta-analysis of Randomized Trials on the Safety of Vascular Closure Devices for Femoral Arterial Puncture Site Haemostasis.

Authors:  Jun Jiang; Junjie Zou; Hao Ma; Yuanyong Jiao; Hongyu Yang; Xiwei Zhang; Yi Miao
Journal:  Sci Rep       Date:  2015-09-08       Impact factor: 4.379

10.  Early decision-analytic modeling - a case study on vascular closure devices.

Authors:  Alina Brandes; Moritz F Sinner; Stefan Kääb; Wolf H Rogowski
Journal:  BMC Health Serv Res       Date:  2015-10-27       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.